What Is Ozempic (Semaglutide)?
The first GLP-1 receptor agonist to receive a license to treat type 2 diabetes became semaglutide under the brand name Ozempic. It also acts the same way as the natural hormone of the body, GLP-1, since insulin prevents the glucagon, slows the emptying of the stomach, and lessens the appetite. The treatments do not aid individuals in...
Gold subscription required
The Lifestyle category requires a Gold subscription or above.
Subscribe — from $4.99/moAlready a subscriber? Log in
